BIO-TECHNE CORPBIO-TECHNE CORPBIO-TECHNE CORP

BIO-TECHNE CORP

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪7.07 B‬EUR
‪156.91 M‬EUR
‪1.08 B‬EUR
‪156.31 M‬
Beta (1Y)
0.84
Employees (FY)
‪3.1 K‬
Change (1Y)
+50 +1.64%
Revenue / Employee (1Y)
‪349.06 K‬EUR
Net income / Employee (1Y)
‪50.62 K‬EUR

About Bio-Techne Corp


CEO
Kim Kelderman
Headquarters
Minneapolis
Founded
1976
FIGI
BBG01TNXD4P7
Bio-Techne Corp. is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. It operates through the Protein Sciences, and Diagnostics and Genomics segments. The Protein Sciences segment develops and manufactures purified proteins, and reagent solutions. The Diagnostics and Genomics segment develops and manufactures diagnostic products. The company was founded in 1976 and is headquartered in Minneapolis, MN.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:

See all ideas 

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Curated watchlists where 1TECH is featured.

Check out other big names from the same industry as 1TECH.

Frequently Asked Questions


The current price of 1TECH is 44.6 EUR — it has increased by 1.36% in the past 24 hours. Watch BIO-TECHNE CORP stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on MIL exchange BIO-TECHNE CORP stocks are traded under the ticker 1TECH.
1TECH stock has risen by 1.36% compared to the previous week, the month change is a 1.36% rise, over the last year BIO-TECHNE CORP has showed a 1.36% increase.
We've gathered analysts' opinions on BIO-TECHNE CORP future price: according to them, 1TECH price has a max estimate of 82.54 EUR and a min estimate of 44.31 EUR. Watch 1TECH chart and read a more detailed BIO-TECHNE CORP stock forecast: see what analysts think of BIO-TECHNE CORP and suggest that you do with its stocks.
1TECH stock is 1.35% volatile and has beta coefficient of 0.84. Track BIO-TECHNE CORP stock price on the chart and check out the list of the most volatile stocks — is BIO-TECHNE CORP there?
Yes, you can track BIO-TECHNE CORP financials in yearly and quarterly reports right on TradingView.
BIO-TECHNE CORP is going to release the next earnings report on May 7, 2025. Keep track of upcoming events with our Earnings Calendar.
1TECH earnings for the last quarter are 0.41 EUR per share, whereas the estimation was 0.37 EUR resulting in a 8.74% surprise. The estimated earnings for the next quarter are 0.47 EUR per share. See more details about BIO-TECHNE CORP earnings.
BIO-TECHNE CORP revenue for the last quarter amounts to ‪286.93 M‬ EUR, despite the estimated figure of ‪276.06 M‬ EUR. In the next quarter, revenue is expected to reach ‪293.20 M‬ EUR.
1TECH net income for the last quarter is ‪33.70 M‬ EUR, while the quarter before that showed ‪30.17 M‬ EUR of net income which accounts for 11.69% change. Track more BIO-TECHNE CORP financial stats to get the full picture.
Yes, 1TECH dividends are paid quarterly. The last dividend per share was 0.076 EUR. As of today, Dividend Yield (TTM)% is 0.63%. Tracking BIO-TECHNE CORP dividends might help you take more informed decisions.
BIO-TECHNE CORP dividend yield was 0.45% in 2024, and payout ratio reached 30.61%. The year before the numbers were 0.39% and 18.16% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of May 4, 2025, the company has ‪3.1 K‬ employees. See our rating of the largest employees — is BIO-TECHNE CORP on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BIO-TECHNE CORP EBITDA is ‪354.32 M‬ EUR, and current EBITDA margin is 31.47%. See more stats in BIO-TECHNE CORP financial statements.
Like other stocks, 1TECH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIO-TECHNE CORP stock right from TradingView charts — choose your broker and connect to your account.